Cargando…
Celecoxib attenuates hepatocellular proliferative capacity during hepatocarcinogenesis by modulating a PTEN/NF-κB/PRL-3 pathway
Although the efficacy of celecoxib on various cancer cell behaviors, including aberrant proliferation, in cultured hepatocellular carcinoma (HCC) cells has been demonstrated, whether celecoxib regulates cell proliferation by targeting PRL-3-associated signaling transduction during hepatocarcinogenes...
Autores principales: | Zhang, Cong, Zhou, Junxuan, Hu, Junjie, Lei, Sheng, Yuan, Ming, Chen, Liang, Wang, Guihong, Qiu, Zhenpeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society of Chemistry
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065693/ https://www.ncbi.nlm.nih.gov/pubmed/35515542 http://dx.doi.org/10.1039/c9ra00429g |
Ejemplares similares
-
Celecoxib attenuates hepatosteatosis by impairing de novo lipogenesis via Akt‐dependent lipogenic pathway
por: Zhang, Cong, et al.
Publicado: (2022) -
The Role of NF-κB in PPARα-Mediated Hepatocarcinogenesis
por: Glauert, Howard P., et al.
Publicado: (2008) -
NF-κB, JNK, and TLR Signaling Pathways in Hepatocarcinogenesis
por: Maeda, Shin
Publicado: (2010) -
Celastrol delays hepatic steatosis and carcinogenesis in a rapid AKT/c-Met-transfected hepatocellular carcinoma model via suppressing fatty acid synthase expression and AKT/ERK phosphorylation
por: Hu, Junjie, et al.
Publicado: (2018) -
Antiproliferative effect of urolithin A, the ellagic acid-derived
colonic metabolite, on hepatocellular carcinoma HepG2.2.15 cells by targeting
Lin28a/let-7a axis
por: Qiu, Zhenpeng, et al.
Publicado: (2018)